The news: People with coronavirus appear to be most infectious within their first week of experiencing symptoms, according to research published in Nature today.
The study: Researchers analyzed data from nine patients with “relatively mild” coronavirus symptoms in Munich, Germany, to see how infectious they were across a 14-day period. Specifically, they checked the viral load in samples from throat and lung swabs, sputum (coughed-up saliva and mucus), stool, blood, and urine.
What did they find? They found covid-19 was replicating in the throat, with concentrations of the virus peaking during the first five days after symptoms started—although it was still possible to detect it after symptoms stopped. They didn’t detect coronavirus in blood, stool, or urine samples. Notably, four of the nine patients also lost their sense of taste or smell, symptoms researchers at King’s College London recently found form a “strong predictor” that someone has been infected (although they have yet to be added to the World Health Organization’s covid-19 symptom list).
More on coronavirus
Our most essential coverage of covid-19 is free, including:
Newsletter: Coronavirus Tech Report
Zoom show: Radio Corona
The researchers’ recommendations: It’s wise to avoid drawing too sweeping conclusions from such a small study. More research from a larger pool of patients is needed to confirm the results. However, the researchers say their findings suggest that measures to contain viral spread should focus on transmission from people’s mouths (droplets, in the scientific jargon), rather than objects, materials, or surfaces. That could lend more weight to the argument in favor of wearing a mask or other face covering while in public. The current official advice in the US is that it’s unnecessary, but officials are currently assessing whether it’s time to revise that stance.
The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.
Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.
Anti-aging drugs are being tested as a way to treat covid
Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.
Why China is still obsessed with disinfecting everything
Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.